Kimberly-Clark de México (KIMBERA) Q4 2025 earnings summary

Executive summary

• Q4 2025 net sales reached MXN 14.1 billion, up 2.1% year-over-year, with consumer products driving growth and export sales declining as tissue was shifted to higher-value domestic products.

• Sequential improvement from Q3 to Q4, with sales up 4.8% and consumer products up 8.5%, led by volume, innovation, and strong brand performance.

• Gross profit rose 5.4% in Q4 with a margin of 40.4%, supported by disciplined revenue management and cost tailwinds.

• Net income for Q4 was MXN 2.2 billion, EPS MXN 0.73, up 23% year-over-year; full-year sales hit a record MXN 55.4 billion.

• Strong balance sheet with net debt to EBITDA at 1.0x and cash of MXN 9.7 billion.

Financial highlights

• Operating profit grew 9.2% in Q4, with margin expanding to 22.9%.

• EBITDA for Q4 was MXN 3.7 billion, up 6%, with a margin of 26.4%; full-year EBITDA reached MXN 14.1 billion (25.5% margin).

• Cost reduction initiatives delivered MXN 1.95 billion in annual savings.

• CapEx investment totaled MXN 1.8 billion, focused on technology and capacity.

• All debt denominated in Mexican pesos.

Outlook and guidance

• Entering 2026 with strong momentum, expecting continued cost tailwinds from lower raw materials and a stronger peso.

• Plans to strengthen core businesses, accelerate growth in diamond categories, expand into pet food and private label.

• Cost reduction program expected to deliver over MXN 1 billion in 2026.

• Dividend increase in the high single digits and a significant share repurchase program proposed for 2026.

• External risks include tariff uncertainty and softer domestic demand, but mitigating factors include leading category positions and robust execution.